These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8648266)

  • 1. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease.
    Chao J; Schmaier A; Chen LM; Yang Z; Chao L
    J Lab Clin Med; 1996 Jun; 127(6):612-20. PubMed ID: 8648266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy.
    Ma JX; King LP; Yang Z; Crouch RK; Chao L; Chao J
    Curr Eye Res; 1996 Nov; 15(11):1117-23. PubMed ID: 8950506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
    Wolf WC; Harley RA; Sluce D; Chao L; Chao J
    J Histochem Cytochem; 1999 Feb; 47(2):221-8. PubMed ID: 9889257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli.
    Chai KX; Chen LM; Chao J; Chao L
    J Biol Chem; 1993 Nov; 268(32):24498-505. PubMed ID: 8227002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney.
    Chen LM; Song Q; Chao L; Chao J
    Kidney Int; 1995 Sep; 48(3):690-7. PubMed ID: 7474653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry, regulation and potential function of kallistatin.
    Chao J; Chao L
    Biol Chem Hoppe Seyler; 1995 Dec; 376(12):705-13. PubMed ID: 9072045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence.
    Zhou GX; Chao L; Chao J
    J Biol Chem; 1992 Dec; 267(36):25873-80. PubMed ID: 1334488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease.
    Stadnicki A; Mazurek U; Gonciarz M; Plewka D; Nowaczyk G; Orchel J; Pastucha E; Plewka A; Wilczok T; Colman RW
    Dig Dis Sci; 2003 Mar; 48(3):615-23. PubMed ID: 12757180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression of rat kallistatin gene.
    Chai KX; Chen VC; Ni A; Lindpaintner K; Rubattu S; Chao L; Chao J
    Biochim Biophys Acta; 1997 Sep; 1353(3):277-86. PubMed ID: 9349723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands.
    Wolf WC; Harley RA; Sluce D; Chao L; Chao J
    Histochem Cell Biol; 1998 Nov; 110(5):477-84. PubMed ID: 9826127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.
    Chen VC; Chao L; Chao J
    J Biol Chem; 2000 Dec; 275(49):38457-66. PubMed ID: 10993887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin.
    Bläckberg M; Berling R; Ohlsson K
    Pancreas; 1999 Nov; 19(4):325-34. PubMed ID: 10547191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural elements of kallistatin required for inhibition of angiogenesis.
    Miao RQ; Chen V; Chao L; Chao J
    Am J Physiol Cell Physiol; 2003 Jun; 284(6):C1604-13. PubMed ID: 12734113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling.
    Chao J; Miao RQ; Chen V; Chen LM; Chao L
    Biol Chem; 2001 Jan; 382(1):15-21. PubMed ID: 11258665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein.
    Chen VC; Chao L; Chao J
    J Biol Chem; 2000 Dec; 275(51):40371-7. PubMed ID: 10991942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis.
    Chen VC; Chao L; Chao J
    Biochim Biophys Acta; 2000 Jun; 1479(1-2):237-46. PubMed ID: 10862973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
    Stadnicki A; Mazurek U; Plewka D; Wilczok T
    Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue kallikrein inhibitors in mammals.
    Chao J; Chai KX; Chao L
    Immunopharmacology; 1996 May; 32(1-3):67-72. PubMed ID: 8796269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallistatin is a potent new vasodilator.
    Chao J; Stallone JN; Liang YM; Chen LM; Wang DZ; Chao L
    J Clin Invest; 1997 Jul; 100(1):11-7. PubMed ID: 9202051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human kallistatin, a new tissue kallikrein-binding protein: purification and characterization.
    Wang MY; Day J; Chao L; Chao J
    Adv Exp Med Biol; 1989; 247B():1-8. PubMed ID: 2558505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.